Janney Montgomery Scott LLC Intellia Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$31.62 - $45.78 $210,778 - $305,169	6,666 Added 128.29%	11,862 $375,000
Q2 2023 Jul 26, 2023	SELL	$34.58 - $46.03 $6,051 - $8,055	-175 Reduced 3.26%	5,196 $212,000
Q1 2023 Apr 28, 2023	BUY	$33.3 - $44.82 $178,854 - $240,728	5,371 New	5,371 $200,000
Q3 2022 Oct 25, 2022	BUY	$53.92 - $71.7 $37,959 - $50,476	704 Added 5.87%	12,691 $710,000
Q2 2022 Aug 03, 2022	SELL	$38.49 - $76.21 $20,900 - $41,382	-543 Reduced 4.33%	11,987 $624,000
Q1 2022 May 04, 2022	BUY	$58.27 - $118.99 $18,529 - $37,838	318 Added 2.6%	12,530 $911,000
Q4 2021 Jan 27, 2022	BUY	$100.76 - $138.36 $353,566 - $485,505	3,509 Added 40.32%	12,212 $1.44 Million
Q3 2021 Oct 29, 2021	SELL	$132.37 - $176.78 $59,698 - $79,727	-451 Reduced 4.93%	8,703 $1.17 Million
Q2 2021 Jul 26, 2021	SELL	$60.88 - $161.91 $42,737 - $113,660	-702 Reduced 7.12%	9,154 $1.48 Million
Q1 2021 Apr 27, 2021	BUY	$46.59 - $83.68 $62,523 - $112,298	1,342 Added 15.76%	9,856 $791,000
Q4 2020 Jan 25, 2021	BUY	$18.83 - $63.53 $160,318 - $540,894	8,514 New	8,514 $463,000
Q3 2019 Oct 29, 2019	SELL	$13.07 - $18.51 $420,657 - $595,744	-32,185 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$13.88 - $18.41 $16,683 - $22,128	1,202 Added 3.88%	32,185 $527,000
Q1 2019 Apr 30, 2019	BUY	$12.79 - $17.62 $24,761 - $34,112	1,936 Added 6.67%	30,983 $529,000
Q4 2018 Feb 01, 2019	SELL	$11.39 - $27.13 $11 - $27	-1 Reduced -0.0%	29,047 $396,000
Q3 2018 Nov 05, 2018	SELL	$25.78 - $32.6 $44,470 - $56,235	-1,725 Reduced 5.61%	29,048 $831,000
Q2 2018 Jul 24, 2018	SELL	$20.02 - $30.79 $4,764 - $7,328	-238 Reduced 0.77%	30,773 $842,000
Q1 2018 Apr 19, 2018	SELL	$19.43 - $34.95 $47,448 - $85,347	-2,442 Reduced 7.3%	31,011 $654,000
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $581,747 - $1.04 Million	33,453	33,453 $643,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$150 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$118 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.9 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.5 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account